Taiwan · Delayed Price · Currency is TWD Pet Pharm Biotech Statistics
Total Valuation
TPEX:7762 has a market cap or net worth of TWD 3.35 billion. The enterprise value is 3.24 billion.
| Market Cap | 3.35B |
| Enterprise Value | 3.24B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | Jul 20, 2026 |
Share Statistics
TPEX:7762 has 58.09 million shares outstanding. The number of shares has increased by 24.82% in one year.
| Current Share Class | 58.09M |
| Shares Outstanding | 58.09M |
| Shares Change (YoY) | +24.82% |
| Shares Change (QoQ) | +11.55% |
| Owned by Insiders (%) | 12.75% |
| Owned by Institutions (%) | 5.11% |
| Float | 38.70M |
Valuation Ratios
The trailing PE ratio is 112.09.
| PE Ratio | 112.09 |
| Forward PE | n/a |
| PS Ratio | 12.62 |
| PB Ratio | 2.87 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | 75.80 |
| P/OCF Ratio | 48.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 48.58, with an EV/FCF ratio of 73.27.
| EV / Earnings | 107.90 |
| EV / Sales | 12.20 |
| EV / EBITDA | 48.58 |
| EV / EBIT | 143.22 |
| EV / FCF | 73.27 |
Financial Position
The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.09.
| Current Ratio | 6.03 |
| Quick Ratio | 3.39 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.61 |
| Debt / FCF | 2.42 |
| Interest Coverage | 15.68 |
Financial Efficiency
Return on equity (ROE) is 2.88% and return on invested capital (ROIC) is 1.21%.
| Return on Equity (ROE) | 2.88% |
| Return on Assets (ROA) | 1.15% |
| Return on Invested Capital (ROIC) | 1.21% |
| Return on Capital Employed (ROCE) | 1.79% |
| Weighted Average Cost of Capital (WACC) | 7.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.22 |
| Inventory Turnover | 11.30 |
Taxes
| Income Tax | -723,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.88% in the last 52 weeks. The beta is 0.62, so TPEX:7762's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -18.88% |
| 50-Day Moving Average | 49.72 |
| 200-Day Moving Average | 58.17 |
| Relative Strength Index (RSI) | 45.80 |
| Average Volume (20 Days) | 64,790 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7762 had revenue of TWD 265.54 million and earned 30.03 million in profits. Earnings per share was 0.51.
| Revenue | 265.54M |
| Gross Profit | 140.60M |
| Operating Income | 22.62M |
| Pretax Income | 29.03M |
| Net Income | 30.03M |
| EBITDA | 57.15M |
| EBIT | 22.62M |
| Earnings Per Share (EPS) | 0.51 |
Balance Sheet
The company has 218.91 million in cash and 107.09 million in debt, with a net cash position of 111.83 million or 1.93 per share.
| Cash & Cash Equivalents | 218.91M |
| Total Debt | 107.09M |
| Net Cash | 111.83M |
| Net Cash Per Share | 1.93 |
| Equity (Book Value) | 1.17B |
| Book Value Per Share | 20.42 |
| Working Capital | 405.60M |
Cash Flow
In the last 12 months, operating cash flow was 69.18 million and capital expenditures -24.96 million, giving a free cash flow of 44.22 million.
| Operating Cash Flow | 69.18M |
| Capital Expenditures | -24.96M |
| Depreciation & Amortization | 34.53M |
| Net Borrowing | -102.90M |
| Free Cash Flow | 44.22M |
| FCF Per Share | 0.76 |
Margins
Gross margin is 52.95%, with operating and profit margins of 8.52% and 11.31%.
| Gross Margin | 52.95% |
| Operating Margin | 8.52% |
| Pretax Margin | 10.93% |
| Profit Margin | 11.31% |
| EBITDA Margin | 21.52% |
| EBIT Margin | 8.52% |
| FCF Margin | 16.65% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.42%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.42% |
| Dividend Growth (YoY) | 183.61% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 16.83% |
| Buyback Yield | -24.82% |
| Shareholder Yield | -24.39% |
| Earnings Yield | 0.90% |
| FCF Yield | 1.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2026. It was a forward split with a ratio of 1.015.
| Last Split Date | Jul 20, 2026 |
| Split Type | Forward |
| Split Ratio | 1.015 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |